CAF-derived miR-146a-5p can promote stemness and enhance chemoresistance in urothelial bladder cancer via regulating YY1/SVEP1 and ARID1A/PRKAA2 signal pathways (186). Here, ARID1A is linked to bladder transitional cell carcinoma.